Registered entities
Aeovian Pharmaceuticals, Inc.
Reg. No. 461226196United States
Innovation
6 patent families (2 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace steady. Cited 590 times.
| Year | Filings |
|---|---|
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 4 |
| 2024 | 3 |
| 2025 | 4 |
| 2026 | 4 |
Social engagement
Social engagement: 1.9K social following, 1 post in the last 12 months — below the industry typical range.
Investor mix
17 investors on record; lead investors include Hevolution, Sofinnova Investments, VenBio, Luma Group.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 10 | 59% |
| Private equity | 1 | 6% |
| Other / undisclosed | 6 | 35% |
